Minnie Baylor-Henry is currently the Worldwide Vice President for Regulatory Affairs, Johnson & Johnson Medical Devices & Diagnostics. In this capacity, she is responsible for coordinating the regulatory strategy for J&J’s device companies. Prior to joining J&J, Minnie was a Consultant in the Life Sciences Regulatory Practice at Deloitte & Touche LLP, with clients in the pharmaceutical, device and consumer industries. Before Deloitte, she was the Vice President for Global Regulatory Affairs OTC, McNeil Consumer Healthcare, a Johnson & Johnson Company. Minnie also worked for Johnson & Johnson Pharmaceutical Research & Development (“PRD”), as a Senior Director, Regulatory Affairs, where she was responsible for the regulatory oversight for promotional activities at several J&J Companies. Before joining J&J in July 1999, Minnie was the Director of the Division of Drug Marketing, Advertising, and Communications (“DDMAC”), US Food & Drug Administration’s (“FDA”) from 1995-1999. Before becoming the Director, she worked as a DDMAC Regulatory Review Officer and Branch Chief. She also has served as the FDA’s National Health Fraud Coordinator in the Office of Regulatory Affairs. Minnie is a pharmacist and an attorney. She received her pharmacy degree from Howard University’s College of Pharmacy and her law degree from Catholic University’s Columbus School of Law. Minnie is active in several professional organizations, including serving as the President-Elect of the DIA Board and Immediate Past Board Chair for FDLI.